Dexamethasone enhances the efficacy of atorvastatin in inhibiting excessively inflammation-induced abnormal angiogenesis by regulating macrophages
Abstract Background We have recently showed that atorvastatin (ATO) combined with low dose of dexamethasone (DEX) was more efficacious in treating patients with chronic subdural haematoma (CSDH) than ATO monotherapy. This study was designed to investigate the underlying mechanisms of the improved ef...
Main Authors: | Zhitao Gong, Daqiang Zhan, Meng Nie, Xiaochun Li, Chuang Gao, Xuanhui Liu, Tangtang Xiang, Jiangyuan Yuan, Weiwei Jiang, Jinhao Huang, Wei Quan, Dong Wang, Ye Tian, Hengjie Yuan, Jianning Zhang, Rongcai Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-021-02257-1 |
Similar Items
-
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases
by: Jiangyuan Yuan, et al.
Published: (2021-07-01) -
Subdural haematomas drain into the extracranial lymphatic system through the meningeal lymphatic vessels
by: Xuanhui Liu, et al.
Published: (2020-02-01) -
Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma
by: Annabel Allison, et al.
Published: (2019-12-01) -
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
by: Angelos G. Kolias, et al.
Published: (2018-12-01) -
Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis
by: Xinjie Zhang, et al.
Published: (2021-09-01)